Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea

Acta Pharmacologica Sinica

Volumn 33, Issue 12, 2012, Pages 1533-1541

  Ling, Jia Xin ^a   Wei, Fei ^a   Li, Ning ^a   Li, Jin Lin ^a   Chen, Liang Jun ^a   Liu, Yuan Yuan ^a   Luo, Fan ^a   Xiong, Hai Rong ^a   Hou, Wei ^a   Yang, Zhan Qiu ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Antiviral agent; Epigallocatechin gallate (EGCG); Influenza A virus; Oseltamivir; ROS

Indexed keywords

EPIGALLOCATECHIN GALLATE; OSELTAMIVIR; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELL LEVEL; CELL STRAIN; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A; INFLUENZA VIRUS A; INHIBITION KINETICS; LUNG PARENCHYMA; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; TEA; VIRUS HEMAGGLUTINATION; VIRUS INHIBITION; VIRUS PNEUMONIA; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CAMELLIA SINENSIS; CATECHIN; CELL LINE; CELL SURVIVAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; GUINEA PIGS; HEMAGGLUTINATION TESTS; HEMAGGLUTINATION, VIRAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, VIRAL; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84870853797     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.80     Document Type: Article

References (30)

1. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefanoF, et al. Influenza and the rates of hospitalization for respiratorydisease among infants and young children. N Engl J Med 2000; 342:232-9
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, CoxNJ, et al. Influenza-associated hospitalizations in the United States.Jama 2004; 292: 1333-40
3. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD,Hollingsworth TD, et al. Pandemic potential of a strain of influenza A(H1N1): early findings. Science 2009; 324: 1557-61
4. Scalera NM, Mossad SB. The first pandemic of the 21st century:a review of the 2009 pandemic variant influenza A (H1N1) virus.Postgrad Med 2009; 121: 43-7
5. Goodman AG, Heinen PP, Guerra S, Vijayan A, Sorzano CO, GomezCE, et al. A human multi-epitope recombinant vaccinia virus as auniversal T cell vaccine candidate against influenza virus. PLoS One2011; 6: e25938
6. Couch RB. Prevention and treatment of influenza. N Engl J Med2000; 343: 1778-87
7. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med2005; 353: 1363-73
8. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, BrightRA, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to2008. Antimicrob Agents Chemother 2008; 52: 3284-92
9. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClintonRC, Marshall SA, et al. Infections with oseltamivir-resistant influenzaA(H1N1) virus in the United States. Jama 2009; 301: 1034-41
10. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Oseltamivirresistantinfluenza viruses A (H1N1), Norway, 2007-08. Emerg infectdis 2009; 15: 155-62
11. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B,et al. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08season. Emerg infect dis 2009; 15: 552-60
12. Friedman M. Overview of antibacterial, antitoxin, antiviral, and antifungalactivities of tea flavonoids and teas. Mol Nutr Food Res 2007;51: 116-34
13. Mollace V, Nottet HS, Clayette P, Turco MC, Muscoli C, Salvemini D, etal. Oxidative stress and neuroAIDS: triggers, modulators and novelantioxidants. Trends Neurosci 2001; 24: 411-6
14. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, et al.Mitochondrial injury, oxidative stress, and antioxidant gene expressionare induced by hepatitis C virus core protein. Gastroenterology 2002;122: 366-75
15. Beck MA, Handy J, Levander OA. The role of oxidative stress in viralinfections. Ann N Y Acad Sci 2000; 917: 906-12
16. Shi L, Xiong H, He J, Deng H, Li Q, Zhong Q, et al. Antiviral activity ofarbidol against influenza A virus, respiratory syncytial virus, rhinovirus,coxsackie virus and adenovirus in vitro and in vivo. Arch Virol 2007;152: 1447-55
17. Song JM, Lee KH, Seong BL. Antiviral effect of catechins in green teaon influenza virus. Antiviral Res 2005; 68: 66-74
18. Kim Y, Narayanan S, Chang KO. Inhibition of influenza virus replicationby plant-derived isoquercetin. Antiviral Res 2010; 88: 227-35
19. Chidlow GR, Harnett GB, Speers DJ, Smith DW, Wang J, Yang Y.Evaluation of real-time reverse transcriptase PCR assays for detectionof pandemic influenza A/H1N1 2009 virus. J Clin Microbiol 2011; 49:3444-5
20. Muench LJRaH. A Simple method of estimating fifty per centedpionts. Am J Epidemiol 1938; 27: 493-97
21. Snelgrove RJ, Edwards L, Rae AJ, Hussell T. An absence of reactiveoxygen species improves the resolution of lung influenza infection.Eur J Immunol 2006; 36: 1364-73
22. Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, Shimamura T.Inhibitionof the infectivity of influenza virus by tea polyphenols. AntiviralRes 1993; 21: 289-99
23. Jackson AC, Kammouni W, Zherebitskaya E, Fernyhough P. Role ofoxidative stress in rabies virus infection of adult mouse dorsal rootganglion neurons. J Virol 2010; 84: 4697-705
24. Vlahos R, Stambas J, Bozinovski S, Broughton BR, Drummond GR,Selemidis S. Inhibition of Nox2 oxidase activity ameliorates influenzaA virus-induced lung inflammation. PLoS Pathog 2011; 7: e1001271
25. Korenaga M, Wang T, Li Y, Showalter LA, Chan T, Sun J, et al. HepatitisC virus core protein inhibits mitochondrial electron transport and increasesreactive oxygen species (ROS) production. J BiolChem 2005;280: 37481-8
26. Ming-Ju H, Yih-Shou H, Tzy-Yen C, Hui-Ling C. Hepatitis C virus E2 proteininduce reactive oxygen species (ROS)-related fibrogenesis in theHSC-T6 hepatic stellate cell line. J Cell Biochem 2011; 112: 233-43
27. Baruchel S, Wainberg MA. The role of oxidative stress in diseaseprogressionin individuals infected by the human immunodeficiencyvirus. J Leukoc Biol 1992; 52: 111-4
28. Tardif KD, Waris G, Siddiqui A. Hepatitis C virus, ER stress, and oxidativestress. Trends Microbiol 2005; 13: 159-63
29. Gangehei L, Ali M, Zhang W, Chen Z, Wakame K, Haidari M. Oligonola low molecular weight polyphenol of lychee fruit extract inhibits proliferationof influenza virus by blocking reactive oxygen species-dependentERK phosphorylation. Phytomedicine 2010; 17: 1047-56
30. Ho HY, Cheng ML, Weng SF, Leu YL, Chiu DT. Antiviral effect of epigallocatechingallate on enterovirus 71. J Agric Food Chem 2009; 57:6140-7.